89 related articles for article (PubMed ID: 9708513)
1. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging.
Stokkel MP; Terhaard CH; Mertens IJ; Hordijk GJ; van Rijk PP
J Nucl Med; 1998 Aug; 39(8):1385-7. PubMed ID: 9708513
[TBL] [Abstract][Full Text] [Related]
2. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
[TBL] [Abstract][Full Text] [Related]
3. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
Cobben DC; van der Laan BF; Maas B; Vaalburg W; Suurmeijer AJ; Hoekstra HJ; Jager PL; Elsinga PH
J Nucl Med; 2004 Feb; 45(2):226-31. PubMed ID: 14960640
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
Bongers V; Hobbelink MG; van Rijk PP; Hordijk GJ
Cancer Biother Radiopharm; 2002 Jun; 17(3):303-6. PubMed ID: 12136522
[TBL] [Abstract][Full Text] [Related]
5. F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
Kim HJ; Boyd J; Dunphy F; Lowe V
Clin Nucl Med; 1998 Nov; 23(11):750-2. PubMed ID: 9814562
[TBL] [Abstract][Full Text] [Related]
6. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
Terhaard CH; Bongers V; van Rijk PP; Hordijk GJ
Head Neck; 2001 Nov; 23(11):933-41. PubMed ID: 11754496
[TBL] [Abstract][Full Text] [Related]
7. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
Brouwer J; de Bree R; Comans EF; Akarriou M; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
Radiother Oncol; 2008 May; 87(2):217-20. PubMed ID: 18329117
[TBL] [Abstract][Full Text] [Related]
8. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera.
Montravers F; Grahek D; Kerrou K; Younsi N; Doublet JD; Gattegno B; Rossert J; Costa de Beauregard MA; Thibault P; Talbot JN
J Nucl Med; 2000 Jan; 41(1):78-84. PubMed ID: 10647608
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Yutani K; Tatsumi M; Shiba E; Kusuoka H; Nishimura T
J Nucl Med; 1999 Jun; 40(6):1003-8. PubMed ID: 10452318
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Stokkel M; Stevens H; Taphoorn M; Van Rijk P
Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
15. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging.
Lowe VJ; Kim H; Boyd JH; Eisenbeis JF; Dunphy FR; Fletcher JW
Radiology; 1999 Sep; 212(3):799-802. PubMed ID: 10478249
[TBL] [Abstract][Full Text] [Related]
16. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
Cook GJ; Houston S; Barrington SF; Fogelman I
J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
de Bree R; van der Putten L; van Tinteren H; Wedman J; Oyen WJ; Janssen LM; van den Brekel MW; Comans EF; Pruim J; Takes RP; Hobbelink MG; Valdés Olmos R; van der Laan BF; Boers M; Hoekstra OS; Leemans CR
Radiother Oncol; 2016 Feb; 118(2):251-6. PubMed ID: 26477395
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
20. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T
J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
